Novel Calcium-Sensing Receptor (CASR) Mutation in a Family with Autosomal Dominant Hypocalcemia Type 1 (ADH1): Genetic Study over Three Generations and Clinical Characteristics
Hormone Research in Paediatrics · 2023
DOI: 10.1159/000529833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone Research in Paediatrics, 2023. Verfasst von Amnon Zung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatrics and Pediatric Endocrinology Unit, Kaplan Medical Center, Rehovot, Israel. Hauptthemen laut MEDLINE: Hypocalcemia, Nephrocalcinosis, Nephrolithiasis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Introduction
Activating mutation of the calcium-sensing receptor gene (CASR) reduces parathyroid hormone secretion and renal tubular reabsorption of calcium, defined as autosomal dominant hypocalcemia type 1 (ADH1). Patients with ADH1 may present with hypocalcemia-induced seizures. Calcitriol and calcium supplementation in symptomatic patients may exacerbate hypercalciuria, leading to nephrocalcinosis, nephrolithiasis, and compromised renal function.
Methods
We report on a family with seven members over three generations with ADH1 due to a novel heterozygous mutation in exon 4 of CASR: c.416T>C.
Results
This mutation leads to substitution of isoleucine with threonine in the ligand-binding domain of CASR. HEK293T cells transfected with wild type or mutant cDNAs demonstrated that p.Ile139Thr substitution led to increased sensitivity of the CASR to activation by extracellular calcium relative to the wild-type CASR (EC50 of 0.88 ± 0.02 mM vs. 1.1 ± 0.23 mM, respectively, p < 0.005). Clinical characteristics included seizures (2 patients), nephrocalcinosis and nephrolithiasis (3 patients), and early lens opacity (2 patients). In 3 of the patients, serum calcium and urinary calcium-to-creatinine ratio levels obtained simultaneously over 49 patient-years were highly correlated. Using the age-specific maximal-normal levels of calcium-to-creatinine ratio in the correlation equation, we obtained age-adjusted serum calcium levels that are high enough to reduce hypocalcemia-induced seizures and low enough to reduce hypercalciuria.
Conclusion
We report on a novel CASR mutation in a three-generation kindred. Comprehensive clinical data enabled us to suggest age-specific upper limit of serum calcium levels, considering the association between serum calcium and renal calcium excretion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatrics and Pediatric Endocrinology Unit, Kaplan Medical Center, Rehovot, Israel.
- The Hebrew University of Jerusalem, Jerusalem, Israel.
- Pediatric Endocrinology Unit, Shamir (Assaf Harofeh) Medical Center, Tzrifin, Israel.
- The Genetic Institute, Edith Wolfson Medical Center, Holon, Israel.
- Center for Bone Health and Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Förderung
- NIDDK NIH HHS
Zitieren
APA
Zung, A., Barash, G., Banne, E., & Levine, M. A. (2023). Novel Calcium-Sensing Receptor (CASR) Mutation in a Family with Autosomal Dominant Hypocalcemia Type 1 (ADH1): Genetic Study over Three Generations and Clinical Characteristics. Hormone Research in Paediatrics. https://doi.org/10.1159/000529833
Vancouver
Zung A, Barash G, Banne E, Levine MA. Novel Calcium-Sensing Receptor (CASR) Mutation in a Family with Autosomal Dominant Hypocalcemia Type 1 (ADH1): Genetic Study over Three Generations and Clinical Characteristics. Hormone Research in Paediatrics. 2023. doi:10.1159/000529833
BibTeX
@article{Zung2023,
author = {Zung, Amnon and Barash, Galia and Banne, Ehud and Levine, Michael A},
title = {Novel Calcium-Sensing Receptor (CASR) Mutation in a Family with Autosomal Dominant Hypocalcemia Type 1 (ADH1): Genetic Study over Three Generations and Clinical Characteristics},
journal = {Hormone Research in Paediatrics},
year = {2023},
doi = {10.1159/000529833}
}
EUVIMED